Biochemistry Laboratory, Faculty of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece.
Bioinorg Chem Appl. 2010;2010. doi: 10.1155/2010/731202. Epub 2010 Jun 28.
Metal complexes bearing dichalcogenated imidodiphosphinate R(2)P(E)NP(E)R(2)' ligands (E = O, S, Se, Te), which act as (E,E) chelates, exhibit a remarkable variety of three-dimensional structures. A series of such complexes, namely, square-planar [Cu{(OPPh(2))(OPPh(2))N-O, O}(2)], tetrahedral [Zn{(EPPh(2))(EPPh(2))N-E,E}(2)], E = O, S, and octahedral [Ga{(OPPh(2))(OPPh(2))N-O,O}(3)], were tested as potential inhibitors of either the platelet activating factor (PAF)- or thrombin-induced aggregation in both washed rabbit platelets and rabbit platelet rich plasma. For comparison, square-planar [Ni{(Ph(2)P)(2)N-S-CHMePh-P, P}X(2)], X = Cl, Br, the corresponding metal salts of all complexes and the (OPPh(2))(OPPh(2))NH ligand were also investigated. Ga(O,O)(3) showed the highest anti-PAF activity but did not inhibit the thrombin-related pathway, whereas Zn(S,S)(2), with also a significant PAF inhibitory effect, exhibited the highest thrombin-related inhibition. Zn(O,O)(2) and Cu(O,O)(2) inhibited moderately both PAF and thrombin, being more effective towards PAF. This work shows that the PAF-inhibitory action depends on the structure of the complexes studied, with the bulkier Ga(O,O)(3) being the most efficient and selective inhibitor.
含有二卤代亚膦酸酯 R(2)P(E)NP(E)R(2)'配体的金属配合物(E = O、S、Se、Te),作为(E,E)螯合物,表现出显著的三维结构多样性。一系列这样的配合物,即平面正方形 [Cu{(OPPh(2))(OPPh(2))N-O, O}(2)]、四面体形 [Zn{(EPPh(2))(EPPh(2))N-E, E}(2)]、E = O、S 和八面体形 [Ga{(OPPh(2))(OPPh(2))N-O,O}(3)],被测试为血小板激活因子(PAF)或凝血酶诱导的洗涤兔血小板和兔富含血小板血浆聚集的潜在抑制剂。为了比较,平面正方形 [Ni{(Ph(2)P)(2)N-S-CHMePh-P, P}X(2)]、X = Cl、Br、所有配合物的相应金属盐和(OPPh(2))(OPPh(2))NH 配体也进行了研究。Ga(O,O)(3)表现出最高的抗 PAF 活性,但不抑制凝血酶相关途径,而 Zn(S,S)(2),具有显著的 PAF 抑制作用,表现出最高的凝血酶相关抑制作用。Zn(O,O)(2)和 Cu(O,O)(2)适度抑制 PAF 和凝血酶,对 PAF 更有效。这项工作表明,PAF 抑制作用取决于所研究的配合物的结构,体积较大的 Ga(O,O)(3)是最有效和选择性的抑制剂。